The Utilization of RNA Silencing Technology to Mitigate the Voriconazole Resistance of Aspergillus Flavus; Lipofectamine-Based Delivery

Advanced Pharmaceutical Bulletin
Sanam NamiFarideh Zaini

Abstract

Purpose: Introducing the effect of RNAi in fungi to downregulate essential genes has made it a powerful tool to investigate gene function, with potential strategies for novel disease treatments. Thus, this study is an endeavor to delve into the silencing potentials of siRNA on cyp51A and MDR1 in voriconazole-resistant Aspergillus flavus as the target genes. Methods: In this study, we designed three cyp51A-specific siRNAs and three MDR1-specific siRNAs and after the co-transfection of siRNA into Aspergillus flavus, using lipofectamine, we investigated the effect of different siRNA concentrations (5, 15, 25, 50nM) on cyp51A and MDR1 expressions by qRT-PCR. Finally, the Minimum Inhibitory Concentrations (MICs) of voriconazole for isolates were determined by broth dilution method. Results: Cyp51A siRNA induced 9, 22, 33, 40-fold reductions in cyp51A mRNA expres-sion in a voriconazole-resistant strain following the treatment of the cells with concentrations of 5, 15, 25, 50nM siRNA, respectively. Identically, the same procedure was applied to MDR1, even though it induced 2, 3, 4, 10-fold reductions. The results demonstrated a MIC for voriconazole in the untreated group (4µg per ml), when compared to the group treated with cyp51A-spe...Continue Reading

References

Feb 8, 2003·Journal of Clinical Microbiology·Patrick C Y WooKwok-Yung Yuen
Mar 8, 2005·Fungal Genetics and Biology : FG & B·Hitoshi NakayashikiShigeyuki Mayama
Sep 3, 2005·FEBS Letters·Hitoshi Nakayashiki
Feb 28, 2006·Revista iberoamericana de micología·Jiujiang YuJoan W Bennett
May 29, 2007·Microbiology·M T HedayatiD W Denning
Dec 11, 2007·Biotechnology Letters·Sally E BarnesDavid B Archer
Jan 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshUNKNOWN Infectious Diseases Society of America
Feb 12, 2009·Mycoses·Suganthini KrishnanPranatharthi H Chandrasekar
Jul 25, 2009·Emerging Infectious Diseases·Susan J HowardDavid W Denning
Aug 14, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S J HowardD W Denning
Jan 29, 2010·Applied Microbiology and Biotechnology·Ulrich Kück, Birgit Hoff
Feb 13, 2010·Journal of Molecular Biology·Natallia StrushkevichHee-Won Park
Jul 14, 2010·Biochimica Et Biophysica Acta·B Crešnar, S Petrič
Oct 19, 2010·Applied Microbiology and Biotechnology·Tomer M SalameOded Yarden
Jun 12, 2012·Applied Microbiology and Biotechnology·Rayko Becher, Stefan G R Wirsel
Jun 19, 2012·Molecular Microbiology·Michael E Donaldson, Barry J Saville
May 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan W M van der LindenPaul E Verweij
Nov 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Aline KochKarl-Heinz Kogel

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
PCR

Software Mentioned

Graphpad prism
Cytation5

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.